Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate

Urology

Volumn 62, Issue 6, 2003, Pages 1063-1067

  D'Amico, Anthony V ^a   Tempany, Clare M ^b   Schultz, Delray ^b   Cormack, Robert A ^b   Hurwitz, Mark ^b   Beard, Clair ^b   Albert, Michele ^b   Kooy, Hanne ^b   Jolesz, Ferenc ^b   Richie, Jerome P ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; RADIATION DOSE; RANDOMIZATION;

EID: 0345096670     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00772-6     Document Type: Article

References (22)

1. Catalona W.J., Smith D.S., Ratliff T.L., et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA. 270:1993;948-954.
2. Ragde H., Korb L.J., Elgamal A.A., et al. Modern prostate brachytherapy prostate specific antigen results in 219 patients with up to 12 years of observed follow up . Cancer. 89:2000;135-141.
3. D'Amico A.V., Cormack R., Tempany C.M., et al. Real time magnetic resonance image guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;507-516.
4. Jolesz F.A., Kikinis R. Intraoperative imaging revolutionizes therapy. Diagn Imaging. 17:1995;62-68.
5. Silverman S.G., Jolesz F.A., Newman R.W., et al. Design and implementation of an interventional MR imaging suite. AJR Am J Roentgenol. 168:1997;1465-1471.
6. D'Amico A.V., Davis A., Vargas S.O., et al. Defining the implant treatment volume for patients with low risk prostate cancer does the anterior base need to be treated? Int J Radiat Oncol Phys. 43:1999;587-590.
7. Takashima R., Egawa S., Kuwao S., et al. Anterior distribution of stage T1c nonpalpable tumors in radical prostatectomy specimens. Urology. 59:2002;692-697.
8. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Invest. 6:1998;135-141.
9. Thomas M.D., Cormack R., Tempany C.M., et al. Identifying the predictors of acute urinary retention following magnetic-resonance image guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 47:2000;905-908.
10. Greene F.L., Page D.L., Fleming I.D., et al. Manual for Staging Cancer. 6th ed :2002;Springer-Verlag, New York. pp 337-346.
11. Gleason D.F. Histologic grading and staging of prostatic carcinoma. Tannenbaum M. Urologic Pathology. 1977;171-187 Lea & Febiger, Philadelphia.
12. D'Amico A.V., Cormack R.A., Tempany C.M. MRI-guided diagnosis and treatment of prostate cancer. N Engl J Med. 344:2001;776-777.
13. Hirose M., Bharatha A., Hata N., et al. Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy. Acad Radiol. 9:2002;906-912.
14. Cormack R.A., Tempany C.M., D'Amico A.V. Optimizing target coverage by dosimetric feedback during prostate brachytherapy. Int J Radiat Oncol Biol Phys. 48:2000;1245-1249.
15. Cox J.D. Consensus statement guidelines for PSA following radiation therapy . Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
16. Das P., Chen M., Valentine K., et al. Utilizing the magnitude of PSA bounce following magnetic resonance image guided prostate brachytherapy to distinguish recurrence, benign precipitating factors and idiopathic bounce. Int J Radiat Oncol Biol Phys. 54:2002;698-703.
17. Neter J, Wasserman W, and Kutner M (Eds): Simultaneous Inferences and Other Topics in Regression Analysis-1. Applied Linear Regression Models. Homewood, Illinois, Richard D Irwin, 1983, pp 150-153.
18. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome following radical prostatectomy or external beam radiation therapy for clinically localized prostate cancer in the PSA era. Cancer. 95:2002;281-286.
19. Nag S. Brachytherapy for prostate cancer summary of American Brachytherapy Society recommendations . Semin Urol Oncol. 18:2000;133-136.
20. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-500.
21. Withers H.R. Radiation biology and treatment options in radiation oncology. Cancer Res. 59:1999;1676s-1684s.
22. Opell M.B., Zeng J., Bauer J.J., et al. Investigating the distribution of prostate cancer using three-dimensional computer simulation. Prostate Cancer Prostatic Dis. 5:2002;204-208.